Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT

Acute myeloid leukemia with runt-related transcription factor 1 gene mutation (RUNX1+ AML) is associated with inferior response rates and outcome after conventional chemotherapy. We performed a retrospective, registry-based analysis to elucidate the prognostic value of RUNX1 mutation after allogenei...

Descripción completa

Detalles Bibliográficos
Autores principales: Waidhauser, Johanna, Labopin, Myriam, Esteve, Jordi, Kröger, Nicolaus, Cornelissen, Jan, Gedde-Dahl, Tobias, Van Gorkom, Gwendolyn, Finke, Jürgen, Rovira, Montserrat, Schaap, Nicolaas, Petersen, Eefke, Beelen, Dietrich, Bunjes, Donald, Savani, Bipin, Schmid, Christoph, Nagler, Arnon, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486660/
https://www.ncbi.nlm.nih.gov/pubmed/34059800
http://dx.doi.org/10.1038/s41409-021-01322-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486660/
https://www.ncbi.nlm.nih.gov/pubmed/34059800
http://dx.doi.org/10.1038/s41409-021-01322-w

Ejemplares similares